433 related articles for article (PubMed ID: 33404051)
1. Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer's disease.
Yu W; Jin H; Huang Y
Clin Sci (Lond); 2021 Jan; 135(1):109-126. PubMed ID: 33404051
[TBL] [Abstract][Full Text] [Related]
2. The contribution of mitochondria-associated endoplasmic reticulum membranes (MAMs) dysfunction in Alzheimer's disease and the potential countermeasure.
Li Z; Cao Y; Pei H; Ma L; Yang Y; Li H
Front Neurosci; 2023; 17():1158204. PubMed ID: 36960176
[TBL] [Abstract][Full Text] [Related]
3. On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis.
Area-Gomez E; Schon EA
FASEB J; 2017 Mar; 31(3):864-867. PubMed ID: 28246299
[TBL] [Abstract][Full Text] [Related]
4. Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer's Disease.
Eysert F; Kinoshita PF; Mary A; Vaillant-Beuchot L; Checler F; Chami M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327665
[TBL] [Abstract][Full Text] [Related]
5. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-associated ER membranes and Alzheimer disease.
Area-Gomez E; Schon EA
Curr Opin Genet Dev; 2016 Jun; 38():90-96. PubMed ID: 27235807
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-Associated Membranes (MAMs): A Novel Therapeutic Target for Treating Metabolic Syndrome.
Yang M; Li C; Sun L
Curr Med Chem; 2021; 28(7):1347-1362. PubMed ID: 32048952
[TBL] [Abstract][Full Text] [Related]
8. Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.
Area-Gomez E; Schon EA
J Alzheimers Dis; 2024; 98(4):1243-1275. PubMed ID: 38578892
[TBL] [Abstract][Full Text] [Related]
9. TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease.
Panes-Fernandez J; Godoy PA; Gavilan J; Ramírez-Molina O; Burgos CF; Marileo A; Flores-Núñez O; Castro PA; Moraga-Cid G; Yévenes GE; Muñoz-Montesino C; Fuentealba J
Biomed Pharmacother; 2023 Jun; 162():114596. PubMed ID: 36989728
[TBL] [Abstract][Full Text] [Related]
10. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
Guan PP; Cao LL; Wang P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
[TBL] [Abstract][Full Text] [Related]
12. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-associated ER membranes in Alzheimer disease.
Schon EA; Area-Gomez E
Mol Cell Neurosci; 2013 Jul; 55():26-36. PubMed ID: 22922446
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Β-Peptide Increases Mitochondria-Endoplasmic Reticulum Contact Altering Mitochondrial Function and Autophagosome Formation in Alzheimer's Disease-Related Models.
Leal NS; Dentoni G; Schreiner B; Naia L; Piras A; Graff C; Cattaneo A; Meli G; Hamasaki M; Nilsson P; Ankarcrona M
Cells; 2020 Nov; 9(12):. PubMed ID: 33260715
[TBL] [Abstract][Full Text] [Related]
15. Axonal generation of amyloid-β from palmitoylated APP in mitochondria-associated endoplasmic reticulum membranes.
Bhattacharyya R; Black SE; Lotlikar MS; Fenn RH; Jorfi M; Kovacs DM; Tanzi RE
Cell Rep; 2021 May; 35(7):109134. PubMed ID: 34010653
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease.
Rodríguez-Arribas M; Yakhine-Diop SMS; Pedro JMB; Gómez-Suaga P; Gómez-Sánchez R; Martínez-Chacón G; Fuentes JM; González-Polo RA; Niso-Santano M
Mol Neurobiol; 2017 Oct; 54(8):6287-6303. PubMed ID: 27714635
[TBL] [Abstract][Full Text] [Related]
17. [Pathological changes induced by amyloid-β in Alzheimer's disease].
Takata K; Kitamura Y; Taniguchi T
Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.
Hedskog L; Pinho CM; Filadi R; Rönnbäck A; Hertwig L; Wiehager B; Larssen P; Gellhaar S; Sandebring A; Westerlund M; Graff C; Winblad B; Galter D; Behbahani H; Pizzo P; Glaser E; Ankarcrona M
Proc Natl Acad Sci U S A; 2013 May; 110(19):7916-21. PubMed ID: 23620518
[TBL] [Abstract][Full Text] [Related]
19. Cal'MAM'ity at the Endoplasmic Reticulum-Mitochondrial Interface: A Potential Therapeutic Target for Neurodegeneration and Human Immunodeficiency Virus-Associated Neurocognitive Disorders.
Proulx J; Park IW; Borgmann K
Front Neurosci; 2021; 15():715945. PubMed ID: 34744606
[TBL] [Abstract][Full Text] [Related]
20. Is Alzheimer's disease a disorder of mitochondria-associated membranes?
Schon EA; Area-Gomez E
J Alzheimers Dis; 2010; 20 Suppl 2():S281-92. PubMed ID: 20421691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
